title: Complex role of zinc in methamphetamine toxicity in vitro.
abstract: Methamphetamine is a drug of abuse that can induce oxidative stress and neurotoxicity to dopaminergic neurons. We have previously reported that oxidative stress promotes the liberation of intracellular Zn(2+) from metal-binding proteins, which, in turn, can initiate neuronal injurious signaling processes. Here, we report that methamphetamine mobilizes Zn(2+) in catecholaminergic rat pheochromocytoma (PC12) cells, as measured by an increase in Zn(2+)-regulated gene expression driven by the metal response element transcription factor-1. Moreover, methamphetamine-liberated Zn(2+) was responsible for a pronounced enhancement in voltage-dependent K(+) currents in these cells, a process that normally accompanies Zn(2+)-dependent cell injury. Overnight exposure to methamphetamine induced PC12 cell death. This toxicity could be prevented by the cell-permeant zinc chelator N,N,N', N'-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN), and by over-expression of the Zn(2+)-binding protein metallothionein 3 (MT3), but not by tricine, an extracellular Zn(2+) chelator. The toxicity of methamphetamine to PC12 cells was enhanced by the presence of co-cultured microglia. Remarkably, under these conditions, TPEN no longer protected but, in fact, dramatically exacerbated methamphetamine toxicity, tricine again being without effect. Over-expression of MT3 in PC12 cells did not mimic these toxicity-enhancing actions of TPEN, suggesting that the chelator affected microglial function. Interestingly, P2X receptor antagonists reversed the toxicity-enhancing effect of TPEN. As such, endogenous levels of intracellular Zn(2+) may normally interfere with the activation of P2X channels in microglia. We conclude that Zn(2+) plays a significant but complex role in modulating the cellular response of PC12 cells to methamphetamine exposure in both the absence and presence of microglia.
authors.affiliation: Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. redox@pitt.edu
authors.forename: E
authors.initials: E
authors.lastname: Aizenman
authors.forename: M C
authors.initials: MC
authors.lastname: McCord
authors.forename: R A
authors.initials: RA
authors.lastname: Saadi
authors.forename: K A
authors.initials: KA
authors.lastname: Hartnett
authors.forename: K
authors.initials: K
authors.lastname: He
mesh_terms: D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005029:Ethylenediamines / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D000090023:Metallothionein 3; D008694:Methamphetamine / Q000494:pharmacology*; D017628:Microglia / Q000187:drug effects / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000378:metabolism; D016716:PC12 Cells; D018408:Patch-Clamp Techniques / Q000379:methods; D051381:Rats; D014131:Trace Elements / Q000494:pharmacology*; D014162:Transfection; D015032:Zinc / Q000378:metabolism*
chemical_list: D000697:Central Nervous System Stimulants; D002800:Cholinesterase Inhibitors; D005029:Ethylenediamines; D000090023:Metallothionein 3; D009419:Nerve Tissue Proteins; D014131:Trace Elements; D049452:Green Fluorescent Proteins; D008694:Methamphetamine; C045674:2',3'-O-(2,4,6-trinitro-cyclohexadienylidine)adenosine 5'-triphosphate; D000255:Adenosine Triphosphate; D015032:Zinc; C044387:N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine; D005998:Glycine; C100184:tricine
references.citation: Eur J Neurosci. 2009 Dec;30(12):2250-7
references.pmid: 20092568
references.citation: Glia. 2001 Jul;35(1):53-62
references.pmid: 11424192
references.citation: Ann N Y Acad Sci. 2010 Feb;1187:101-21
references.pmid: 20201848
references.citation: FEBS Lett. 1987 Nov 2;223(2):284-8
references.pmid: 2822487
references.citation: J Physiol. 2009 Sep 15;587(Pt 18):4393-404
references.pmid: 19622611
references.citation: Synapse. 1997 Feb;25(2):176-84
references.pmid: 9021898
references.citation: Exp Neurol. 2004 May;187(1):47-57
references.pmid: 15081587
references.citation: Pflugers Arch. 2004 Jun;448(3):296-303
references.pmid: 15024658
references.citation: J Neurochem. 2008 May;105(3):605-16
references.pmid: 18088364
references.citation: J Pharmacol Exp Ther. 2005 May;313(2):870-6
references.pmid: 15718289
references.citation: Addiction. 2007 Apr;102 Suppl 1:16-32
references.pmid: 17493050
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):1-7
references.pmid: 15163680
references.citation: J Neuroimmunol. 1997 Jul;77(1):1-7
references.pmid: 9209262
references.citation: J Neurosci Methods. 2004 Aug 30;137(2):175-80
references.pmid: 15262058
references.citation: J Neurosci. 1994 Apr;14(4):2260-71
references.pmid: 8158268
references.citation: FASEB J. 2004 Feb;18(2):238-51
references.pmid: 14769818
references.citation: J Neurochem. 2008 Jan;104(1):14-20
references.pmid: 17986229
references.citation: Biochem Biophys Res Commun. 2006 Oct 27;349(3):913-9
references.pmid: 16962563
references.citation: Mol Cell Biol. 2003 Dec;23(23):8471-85
references.pmid: 14612393
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3568-73
references.pmid: 17360683
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):868-73
references.pmid: 15644446
references.citation: Neuroscience. 2003;122(2):499-513
references.pmid: 14614914
references.citation: FASEB J. 2001 Aug;15(10):1745-52
references.pmid: 11481222
references.citation: Neurosci Lett. 2007 May 23;419(1):59-63
references.pmid: 17481810
references.citation: Exp Gerontol. 2008 May;43(5):363-9
references.pmid: 18171607
references.citation: Neurotoxicology. 2008 May;29(3):489-503
references.pmid: 18313142
references.citation: Am Fam Physician. 2007 Oct 15;76(8):1169-74
references.pmid: 17990840
references.citation: Brain Res Bull. 2005 Nov 30;67(6):466-75
references.pmid: 16216695
references.citation: J Neurosci. 2008 May 28;28(22):5827-35
references.pmid: 18509044
references.citation: J Neurosci. 2004 Jun 30;24(26):6028-36
references.pmid: 15229250
references.citation: J Neurosci. 2008 May 28;28(22):5756-61
references.pmid: 18509037
references.citation: Glia. 2008 Jan 1;56(1):89-96
references.pmid: 17955552
references.citation: Brain Res. 2005 Jul 19;1050(1-2):190-8
references.pmid: 15987631
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1381-93
references.pmid: 16839653
references.citation: Neurosci Lett. 2004 Sep 9;367(3):349-54
references.pmid: 15337264
references.citation: J Neurochem. 2009 Jul;110(1):106-17
references.pmid: 19453299
references.citation: J Physiol. 2004 Oct 15;560(Pt 2):505-17
references.pmid: 15331685
references.citation: J Neurosci. 2009 Sep 30;29(39):12284-91
references.pmid: 19793987
references.citation: J Neurosci. 1997 Aug 1;17(15):5711-25
references.pmid: 9221770
references.citation: Purinergic Signal. 2007 Sep;3(4):435-45
references.pmid: 18404456
references.citation: J Pharmacol Exp Ther. 1996 Nov;279(2):515-23
references.pmid: 8930153
references.citation: J Neurosci. 2002 Sep 1;22(17):7408-16
references.pmid: 12196562
references.citation: Crit Rev Neurobiol. 2005;17(2):87-117
references.pmid: 16808729
references.citation: J Neurosci. 2001 May 15;21(10):3303-11
references.pmid: 11331359
references.citation: J Biol Chem. 2004 Feb 6;279(6):4515-22
references.pmid: 14610091
references.citation: Adv Enzyme Regul. 1999;39:157-71
references.pmid: 10470372
references.citation: Prog Neurobiol. 2003 Jul;70(4):363-86
references.pmid: 12963093
references.citation: J Neurochem. 2000 Nov;75(5):1878-88
references.pmid: 11032877
references.citation: J Neurochem. 2009 May;109 Suppl 1:145-52
references.pmid: 19393021
references.citation: Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1219-23
references.pmid: 8108390
references.citation: Brain Res Rev. 2009 May;60(2):379-407
references.pmid: 19328213
references.citation: Curr Protoc Neurosci. 2008 Jul;Chapter 7:Unit 7.18
references.pmid: 18633999
references.citation: Nat Rev Neurosci. 2009 Nov;10(11):780-91
references.pmid: 19826435